Clinical trial
An Exploratory Study to Evaluate the Efficacy and Safety of the Cilostazol-coated BioMimics 3D Stent System in Patients with Peripheral Occlusive Arterial Disease
NCT05759819 is registered in ClinicalTrials.gov with Otsuka Medical Devices Co., Ltd. Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study to Evaluate the Efficacy and Safety of the Cilostazol-coated BioMimics 3D Stent System in Patients with Peripheral Occlusive Arterial Disease
- Lead sponsor
- Otsuka Medical Devices Co., Ltd. Japan
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 10, 2023
- Completion date
- December 31, 2026
- Enrollment
- 24 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.